Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Acta Pharmacol Sin. 2013 Aug;34(8):991-7. doi: 10.1038/aps.2013.71. Epub 2013 Jun 17.
Tumorigenesis is the process by which normal cells evolve the capacity to evade and overcome the constraints usually placed upon their growth and survival. To ensure the integrity of organs and tissues, the balance of cell proliferation and cell death is tightly maintained. The proteins controlling this balance are either considered oncogenes, which promote tumorigenesis, or tumor suppressors, which prevent tumorigenesis. Phosphoinositide 3-kinase enhancer (PIKE) is a family of GTP-binding proteins that possess anti-apoptotic functions and play an important role in the central nervous system. Notably, accumulating evidence suggests that PIKE is a proto-oncogene involved in tumor progression. The PIKE gene (CENTG1) is amplified in a variety of human cancers, leading to the resistance against apoptosis and the enhancement of invasion. In this review, we will summarize the functions of PIKE proteins in tumorigenesis and discuss their potential implications in cancer therapy.
肿瘤发生是指正常细胞获得逃避和克服通常限制其生长和存活的约束的能力的过程。为了确保器官和组织的完整性,细胞增殖和细胞死亡的平衡被严格维持。控制这种平衡的蛋白质要么被认为是致癌基因,促进肿瘤发生,要么被认为是肿瘤抑制基因,防止肿瘤发生。磷酸肌醇 3-激酶增强子(PIKE)是一类具有抗细胞凋亡功能的 GTP 结合蛋白,在中枢神经系统中发挥重要作用。值得注意的是,越来越多的证据表明 PIKE 是一种参与肿瘤进展的原癌基因。PIKE 基因(CENTG1)在多种人类癌症中扩增,导致对细胞凋亡的抵抗和侵袭的增强。在这篇综述中,我们将总结 PIKE 蛋白在肿瘤发生中的作用,并讨论它们在癌症治疗中的潜在意义。